News Snapshot:
Britain’s emergency approval of Pfizer’s vaccine isn’t likely to accelerate the availability of the shot in Asia, as countries work to complete local safety tests Australia said its timeline for the US firm’s jab remains unchanged, with a decision on approval expected by next January Britain’s emergency approval of Pfizer’s vaccine isn’t likely to accelerate the availability of the shot in Asia, as countries work to complete local safety tests. The quick approval of Pfizer’s coronavirus vaccine in the UK isn’t likely to accelerate the availability of the shot in Asia, as countries work to complete local safety tests and...